In our study, at 103, 191, 122, and 191 days after the onset of symptoms, S IgM, N IgG, S IgG, and N total antibodies, respectively, were still at detectable levels in pediatric patients with COVID-19. The gene discussed is CD40LG; the disease is COVID-19.